Abstract 1207: SNS-062 demonstrates efficacy in chronic lymphocytic leukemia in vitro and inhibits C481S mutated Bruton tyrosine kinase

MLA

Amy J. Johnson, et al. “Abstract 1207: SNS-062 Demonstrates Efficacy in Chronic Lymphocytic Leukemia in Vitro and Inhibits C481S Mutated Bruton Tyrosine Kinase.” Cancer Research, vol. 77, July 2017, p. 1207. EBSCOhost, https://doi.org/10.1158/1538-7445.am2017-1207.

APA

Amy J. Johnson, Judith A. Fox, Linda L. Neuman, John C. Byrd, Daphne Guinn, Jennifer A. Woyach, Catherine A. Fabian, Sean D. Reiff, & Wendy Wilson. (2017). Abstract 1207: SNS-062 demonstrates efficacy in chronic lymphocytic leukemia in vitro and inhibits C481S mutated Bruton tyrosine kinase. Cancer Research, 77, 1207. https://doi.org/10.1158/1538-7445.am2017-1207

Chicago

Amy J. Johnson, Judith A. Fox, Linda L. Neuman, John C. Byrd, Daphne Guinn, Jennifer A. Woyach, Catherine A. Fabian, Sean D. Reiff, and Wendy Wilson. 2017. “Abstract 1207: SNS-062 Demonstrates Efficacy in Chronic Lymphocytic Leukemia in Vitro and Inhibits C481S Mutated Bruton Tyrosine Kinase.” Cancer Research 77 (July): 1207. doi:10.1158/1538-7445.am2017-1207.